Added to YB: 2023-08-14
Pitch date: 2023-08-14
SAGE:US [bullish]
Sage Therapeutics, Inc.
-59.81%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes brain health medicines.
Market Cap
$543.6M
Pitch Price
$21.60
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.64
P/E
-1.78
EV/Sales
2.69
Sector
Biotechnology
Category
N/A
Show full summary:
SAGE Therapeutics, Inc. SAGE:US
A summary for this pitch has not been created yet.
Read full article (0 min)